# Regen BioPharma, Inc. (RGBPP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RGBPP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 177.2K | $ -613.7K | $ -285.2K | $ 924.7K | $ -5.88M |
| 2025 | $ 242.2K | $ -1.30M | $ -392.8K | $ 1.20M | $ -6.28M |
| 2024 | $ 248.6K | $ -898.1K | $ -728.6K | $ 814.7K | $ -5.19M |
| 2023 | $ 255.4K | $ 1.10M | $ -188.0K | $ 756.2K | $ -5.10M |
| 2022 | $ 263.1K | $ -4.03M | $ -678.0K | $ 1.27M | $ -8.04M |
| 2021 | $ -2.03M | $ -10.27M | $ -1.30M | $ 3.58M | $ -13.49M |
| 2020 | $ 140.1K | $ 2.37M | $ 800.2K | $ 2.60M | $ -7.33M |
| 2019 | $ 142.0K | $ -3.52M | $ -621.9K | $ 2.15M | $ -10.91M |
| 2018 | $ 264.1K | $ -6.61M | $ -2.08M | $ 1.43M | $ -9.12M |
| 2017 | $ 296.4K | $ -7.85M | $ -2.55M | $ 692.7K | $ -5.25M |
| 2016 | $ 137.6K | $ -6.70M | $ -2.30M | $ 259.5K | $ -586.9K |
| 2015 | $ 261.5K | $ -3.21M | $ -15.46M | $ 222.8K | $ -97.2K |
| 2014 | $ 0 | $ -1.07M | $ -3.15M | $ 126.3K | $ -129.6K |
| 2013 | $ 0 | $ -504.9K | $ -405.1K | $ 0 | $ 115.9K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.16 |
| Liabilities / Eq | -1.05 |
| Current Ratio | 0.05 |

## Other views

- [Metrics](https://sponda.capital/en/RGBPP.md)
- [Charts](https://sponda.capital/en/RGBPP/charts.md)
- [Compare](https://sponda.capital/en/RGBPP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.